Industrial - Machinery
Compare Stocks
2 / 10Stock Comparison
GGG vs EMR
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
GGG vs EMR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Industrial - Machinery | Industrial - Machinery |
| Market Cap | $13.34B | $83.18B |
| Revenue (TTM) | $2.25B | $18.32B |
| Net Income (TTM) | $516M | $2.44B |
| Gross Margin | 52.3% | 39.4% |
| Operating Margin | 26.9% | 19.4% |
| Forward P/E | 25.7x | 22.8x |
| Total Debt | $61M | $13.76B |
| Cash & Equiv. | $624M | $1.54B |
GGG vs EMR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Graco Inc. (GGG) | 100 | 166.7 | +66.7% |
| Emerson Electric Co. (EMR) | 100 | 242.4 | +142.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GGG vs EMR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GGG carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 5.8%, EPS growth 9.2%, 3Y rev CAGR 1.4%
- 233.7% 10Y total return vs EMR's 215.5%
- Lower volatility, beta 0.80, Low D/E 2.3%, current ratio 3.15x
EMR is the clearest fit if your priority is income & stability.
- Dividend streak 37 yrs, beta 1.52, yield 1.4%
- 1.4% yield, 37-year raise streak, vs GGG's 1.3%
- +39.9% vs GGG's -0.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.8% revenue growth vs EMR's 3.0% | |
| Value | PEG 2.59 vs 5.04 | |
| Quality / Margins | 23.0% margin vs EMR's 13.3% | |
| Stability / Safety | Beta 0.80 vs EMR's 1.52, lower leverage | |
| Dividends | 1.4% yield, 37-year raise streak, vs GGG's 1.3% | |
| Momentum (1Y) | +39.9% vs GGG's -0.1% | |
| Efficiency (ROA) | 16.0% ROA vs EMR's 5.8%, ROIC 22.6% vs 8.2% |
GGG vs EMR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
GGG vs EMR — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
GGG leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EMR is the larger business by revenue, generating $18.3B annually — 8.1x GGG's $2.2B. GGG is the more profitable business, keeping 23.0% of every revenue dollar as net income compared to EMR's 13.3%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $2.2B | $18.3B |
| EBITDAEarnings before interest/tax | $690M | $4.7B |
| Net IncomeAfter-tax profit | $516M | $2.4B |
| Free Cash FlowCash after capex | $631M | $3.1B |
| Gross MarginGross profit ÷ Revenue | +52.3% | +39.4% |
| Operating MarginEBIT ÷ Revenue | +26.9% | +19.4% |
| Net MarginNet income ÷ Revenue | +23.0% | +13.3% |
| FCF MarginFCF ÷ Revenue | +28.1% | +17.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.2% | +2.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -2.8% | +28.2% |
Valuation Metrics
GGG leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 26.1x trailing earnings, GGG trades at a 29% valuation discount to EMR's 36.6x P/E. Adjusting for growth (PEG ratio), GGG offers better value at 2.63x vs EMR's 8.11x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $13.3B | $83.2B |
| Enterprise ValueMkt cap + debt − cash | $12.8B | $95.4B |
| Trailing P/EPrice ÷ TTM EPS | 26.09x | 36.61x |
| Forward P/EPrice ÷ next-FY EPS est. | 25.69x | 22.77x |
| PEG RatioP/E ÷ EPS growth rate | 2.63x | 8.11x |
| EV / EBITDAEnterprise value multiple | 17.79x | 18.89x |
| Price / SalesMarket cap ÷ Revenue | 5.96x | 4.62x |
| Price / BookPrice ÷ Book value/share | 5.12x | 4.13x |
| Price / FCFMarket cap ÷ FCF | 20.91x | 31.19x |
Profitability & Efficiency
GGG leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
GGG delivers a 19.7% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $12 for EMR. GGG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to EMR's 0.68x. On the Piotroski fundamental quality scale (0–9), EMR scores 7/9 vs GGG's 5/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +19.7% | +12.1% |
| ROA (TTM)Return on assets | +16.0% | +5.8% |
| ROICReturn on invested capital | +22.6% | +8.2% |
| ROCEReturn on capital employed | +22.0% | +10.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.02x | 0.68x |
| Net DebtTotal debt minus cash | -$563M | $12.2B |
| Cash & Equiv.Liquid assets | $624M | $1.5B |
| Total DebtShort + long-term debt | $61M | $13.8B |
| Interest CoverageEBIT ÷ Interest expense | 209.82x | 6.61x |
Total Returns (Dividends Reinvested)
EMR leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in EMR five years ago would be worth $16,900 today (with dividends reinvested), compared to $10,843 for GGG. Over the past 12 months, EMR leads with a +39.9% total return vs GGG's -0.1%. The 3-year compound annual growth rate (CAGR) favors EMR at 22.6% vs GGG's 2.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -2.0% | +9.3% |
| 1-Year ReturnPast 12 months | -0.1% | +39.9% |
| 3-Year ReturnCumulative with dividends | +6.7% | +84.1% |
| 5-Year ReturnCumulative with dividends | +8.4% | +69.0% |
| 10-Year ReturnCumulative with dividends | +233.7% | +215.5% |
| CAGR (3Y)Annualised 3-year return | +2.2% | +22.6% |
Risk & Volatility
Evenly matched — GGG and EMR each lead in 1 of 2 comparable metrics.
Risk & Volatility
GGG is the less volatile stock with a 0.80 beta — it tends to amplify market swings less than EMR's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EMR currently trades 89.6% from its 52-week high vs GGG's 84.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.80x | 1.52x |
| 52-Week HighHighest price in past year | $95.69 | $165.15 |
| 52-Week LowLowest price in past year | $77.70 | $106.53 |
| % of 52W HighCurrent price vs 52-week peak | +84.0% | +89.6% |
| RSI (14)Momentum oscillator 0–100 | 32.3 | 48.4 |
| Avg Volume (50D)Average daily shares traded | 1.1M | 2.8M |
Analyst Outlook
EMR leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates GGG as "Hold" and EMR as "Buy". Consensus price targets imply 19.1% upside for GGG (target: $96) vs 9.5% for EMR (target: $162). For income investors, EMR offers the higher dividend yield at 1.42% vs GGG's 1.35%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $95.67 | $161.92 |
| # AnalystsCovering analysts | 20 | 41 |
| Dividend YieldAnnual dividend ÷ price | +1.3% | +1.4% |
| Dividend StreakConsecutive years of raises | 20 | 37 |
| Dividend / ShareAnnual DPS | $1.08 | $2.10 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.2% | +1.5% |
GGG leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). EMR leads in 2 (Total Returns, Analyst Outlook). 1 tied.
GGG vs EMR: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is GGG or EMR a better buy right now?
For growth investors, Graco Inc.
(GGG) is the stronger pick with 5. 8% revenue growth year-over-year, versus 3. 0% for Emerson Electric Co. (EMR). Graco Inc. (GGG) offers the better valuation at 26. 1x trailing P/E (25. 7x forward), making it the more compelling value choice. Analysts rate Emerson Electric Co. (EMR) a "Buy" — based on 41 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GGG or EMR?
On trailing P/E, Graco Inc.
(GGG) is the cheapest at 26. 1x versus Emerson Electric Co. at 36. 6x. On forward P/E, Emerson Electric Co. is actually cheaper at 22. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Graco Inc. wins at 2. 59x versus Emerson Electric Co. 's 5. 04x.
03Which is the better long-term investment — GGG or EMR?
Over the past 5 years, Emerson Electric Co.
(EMR) delivered a total return of +69. 0%, compared to +8. 4% for Graco Inc. (GGG). Over 10 years, the gap is even starker: GGG returned +233. 7% versus EMR's +215. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GGG or EMR?
By beta (market sensitivity over 5 years), Graco Inc.
(GGG) is the lower-risk stock at 0. 80β versus Emerson Electric Co. 's 1. 52β — meaning EMR is approximately 89% more volatile than GGG relative to the S&P 500. On balance sheet safety, Graco Inc. (GGG) carries a lower debt/equity ratio of 2% versus 68% for Emerson Electric Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — GGG or EMR?
By revenue growth (latest reported year), Graco Inc.
(GGG) is pulling ahead at 5. 8% versus 3. 0% for Emerson Electric Co. (EMR). On earnings-per-share growth, the picture is similar: Emerson Electric Co. grew EPS 17. 8% year-over-year, compared to 9. 2% for Graco Inc.. Over a 3-year CAGR, EMR leads at 9. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GGG or EMR?
Graco Inc.
(GGG) is the more profitable company, earning 23. 3% net margin versus 12. 7% for Emerson Electric Co. — meaning it keeps 23. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GGG leads at 27. 3% versus 19. 6% for EMR. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GGG or EMR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Graco Inc. (GGG) is the more undervalued stock at a PEG of 2. 59x versus Emerson Electric Co. 's 5. 04x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Emerson Electric Co. (EMR) trades at 22. 8x forward P/E versus 25. 7x for Graco Inc. — 2. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GGG: 19. 1% to $95. 67.
08Which pays a better dividend — GGG or EMR?
All stocks in this comparison pay dividends.
Emerson Electric Co. (EMR) offers the highest yield at 1. 4%, versus 1. 3% for Graco Inc. (GGG).
09Is GGG or EMR better for a retirement portfolio?
For long-horizon retirement investors, Graco Inc.
(GGG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 80), 1. 3% yield, +233. 7% 10Y return). Emerson Electric Co. (EMR) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (GGG: +233. 7%, EMR: +215. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GGG and EMR?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.